Response-guided neoadjuvant sacituzumab govitecan for localized triple-negative breast cancer: results from the NeoSTAR trial

著者: Laura M. Spring, Sara M. Tolaney, Geoffrey Fell, Veerle Bossuyt, Rachel O. Abelman, Bing Wu, Shyamala Maheswaran, Lorenzo Trippa, Amy Comander, Therese M. Mulvey, Sarah A. McLaughlin, Paula D. Ryan, Louise Ryan, Edward Abraham, Aron S. Rosenstock, Ana C. Garrido-Castro, Filipa Lynce, Beverly Moy, Steven J. Isakoff, Nadine Tung, Elizabeth A. Mittendorf, Leif W. Ellisen, Aditya Bardia - Annals of Oncology 2023 被引用: 77